Incannex Healthcare Inc. current report, Q2 FY2023

Incannex Healthcare Limited — Form 6-K Summary

Reporting period: Form 6-K filed May 18, 2023, covering the month of May 2023. Incannex Healthcare Limited is an Australian foreign private issuer that files annual reports on Form 20-F.

Business Context

The filing reports that, on May 16, 2023, Incannex filed an Australian Securities Exchange announcement titled “Psychennex Pty Ltd – Company Update.” The referenced announcement is attached as Exhibit 99.1, but its substantive text is not included in the provided filing content.

Financial and Operating Metrics

The provided filing text does not report revenue, profit or loss, cash flow, margins, debt, liquidity, operating expenses, or other financial metrics.

Material Changes Versus Prior Period

The filing text does not provide a clear comparison with a prior comparable period or describe quantified material changes. Any details regarding Psychennex Pty Ltd are contained in the referenced Exhibit 99.1, which is not provided.

Guidance, Outlook, Risks, and Unusual Items

No guidance, outlook, management commentary, risk factors, contingencies, or unusual financial items are described in the available filing text. The nature and implications of the Psychennex company update cannot be determined from the provided content.

Investor Verification Items

  • Obtain and review Exhibit 99.1, the May 16, 2023 ASX announcement concerning Psychennex Pty Ltd.
  • Verify whether the Psychennex update includes changes to ownership, operations, funding, clinical programs, or strategic plans.
  • Review the company’s latest Form 20-F and other filings for current financial condition, liquidity, cash runway, and material risks.